Diverse CMT2 neuropathies are linked to aberrant G3BP interactions in stress granules

Qinqin Cui1, Hongyun Bi1, Zhanyun Lv1

  • 1Department of Neurobiology and Department of Neurology of Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China; Liangzhu Laboratory, MOE Frontier Science Center for Brain Science and Brain-Machine Integration, State Key Laboratory of Brain-Machine Intelligence, Zhejiang University, Hangzhou 311121, China; NHC and CAMS Key Laboratory of Medical Neurobiology, Zhejiang University, Hangzhou 310058, China.

Cell
|February 4, 2023
PubMed

Insights

Environmental stress causes Charcot-Marie-Tooth type 2 (CMT2) mutant proteins to enter stress granules, disrupting cellular responses. Targeting this interaction alleviates motor deficits, revealing a common link in CMT2 pathogenesis.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Complex diseases arise from gene-environment interactions.
  • Charcot-Marie-Tooth type 2 (CMT2) encompasses genetically diverse neuropathies with similar pathology.
  • The molecular links between different CMT2-causing genes are unclear.

Purpose of the Study:

  • To identify a common molecular mechanism underlying CMT2 pathogenesis.
  • To investigate the role of environmental stress in CMT2.
  • To explore potential therapeutic targets for CMT2.

Main Methods:

  • Investigated the behavior of CMT2-causing mutant proteins under environmental stress.
  • Analyzed protein interactions within stress granules (SGs), focusing on G3BP.
  • Utilized a CMT2D mouse model to assess therapeutic interventions.

Main Results:

  • Many CMT2 mutant proteins enter SGs upon environmental stress.
  • Mutant proteins aberrantly interact with G3BP within SGs, disrupting SG pathways.
  • Disrupting the mutant protein-G3BP interaction rescued SG abnormalities and improved motor function in CMT2D mice.

Conclusions:

  • A stress-dependent molecular link exists across diverse CMT2 mutants.
  • Aberrant G3BP interactions in SGs contribute to CMT2 pathogenesis.
  • Targeting SG abnormalities offers a potential therapeutic strategy for CMT2.

Related Concept Videos

Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.7K
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
4.4K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.5K